Patrick M. Forde

Research interests

Publications

• Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer

  New England Journal of Medicine · 2025 · https://doi.org/10.1056/nejmoa2502931

• Detection and characterization of lung cancer using cell-free DNA fragmentomes

  Nature Communications · 2021 · https://doi.org/10.1038/s41467-021-24994-w

• Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

  Journal for ImmunoTherapy of Cancer · 2021 · https://doi.org/10.1136/jitc-2020-001731

• Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

  Nature · 2021 · https://doi.org/10.1038/s41586-021-03752-4

• Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

  Journal of Thoracic Oncology · 2020 · https://doi.org/10.1016/j.jtho.2020.03.006

• Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer

  JAMA Oncology · 2020 · https://doi.org/10.1001/jamaoncol.2020.5012

• The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis

  Journal of Clinical Investigation · 2019 · https://doi.org/10.1172/jci128654

• Genome-wide cell-free DNA fragmentation in patients with cancer

  Nature · 2019 · https://doi.org/10.1038/s41586-019-1272-6

• Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2018.11.016

• Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen

  Seminars in Arthritis and Rheumatism · 2018 · https://doi.org/10.1016/j.semarthrit.2018.02.011

• Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1716078

• Pneumonitis in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2018.08.2035

• Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

  Cancer Research · 2018 · https://doi.org/10.1158/0008-5472.can-18-1127

• Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy218

• Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

  International Journal of Radiation Oncology*Biology*Physics · 2017 · https://doi.org/10.1016/j.ijrobp.2017.11.041

• Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

  Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-16-0828

Current projects

No projects listed.